抗原-话题@MedSci

#抗原#

244篇内容 | 4318人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1623342, encodeId=eff31623342a2, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Hypertension：抗原提呈细胞介导高盐诱导的肾脏炎症和高血压的发生, objectType=article, longId=178026, objectId=e2df1e8026b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2df1e8026b1, replyNumber=0, likeNumber=53, createdTime=2019-08-22, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2df1e8026b1, moduleTitle=Hypertension：抗原提呈细胞介导高盐诱导的肾脏炎症和高血压的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2df1e8026b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623341, encodeId=b223162334116, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Nat Biotech | 针对肿瘤抗原异质性问题，提出CAR-T与BiTEs联合的免疫疗法，产生强有力的特异性抗肿瘤效应, objectType=article, longId=176417, objectId=1f141e6417a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f141e6417a6, replyNumber=0, likeNumber=30, createdTime=2019-07-31, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f141e6417a6, moduleTitle=Nat Biotech | 针对肿瘤抗原异质性问题，提出CAR-T与BiTEs联合的免疫疗法，产生强有力的特异性抗肿瘤效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f141e6417a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623340, encodeId=3d2b1623340bb, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=中国乙肝表面抗原携带者人数仍为全球多, objectType=article, longId=176365, objectId=b9151e63653f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9151e63653f, replyNumber=0, likeNumber=78, createdTime=2019-07-30, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9151e63653f, moduleTitle=中国乙肝表面抗原携带者人数仍为全球多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9151e63653f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623339, encodeId=a971162333956, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=JAHA：基于人类白细胞抗原的心脏移植受者风险分层, objectType=article, longId=176169, objectId=03071e6169fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03071e6169fb, replyNumber=0, likeNumber=72, createdTime=2019-07-27, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03071e6169fb, moduleTitle=JAHA：基于人类白细胞抗原的心脏移植受者风险分层, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03071e6169fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623338, encodeId=0a191623338e7, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=人类白细胞抗原Ⅰ（HLA-I）影响肿瘤免疫治疗疗效之探索, objectType=article, longId=176071, objectId=6ae71e60715e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ae71e60715e, replyNumber=0, likeNumber=126, createdTime=2019-07-25, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ae71e60715e, moduleTitle=人类白细胞抗原Ⅰ（HLA-I）影响肿瘤免疫治疗疗效之探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ae71e60715e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623337, encodeId=62c9162333e24, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=完全个体化肿瘤免疫疗法：一种针对个体化抗原的自体基因编辑的TCR T细胞疗法（NeoTCR-P1）, objectType=article, longId=175924, objectId=f0c91e5924d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0c91e5924d3, replyNumber=0, likeNumber=105, createdTime=2019-07-23, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0c91e5924d3, moduleTitle=完全个体化肿瘤免疫疗法：一种针对个体化抗原的自体基因编辑的TCR T细胞疗法（NeoTCR-P1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0c91e5924d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623336, encodeId=db651623336cf, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=JCLA：超敏前列腺特异性抗原水平作为机器人辅助根治性前列腺切除术后生化进展的预测指标？, objectType=article, longId=175353, objectId=37da1e53535d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37da1e53535d, replyNumber=0, likeNumber=27, createdTime=2019-07-14, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37da1e53535d, moduleTitle=JCLA：超敏前列腺特异性抗原水平作为机器人辅助根治性前列腺切除术后生化进展的预测指标？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37da1e53535d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623335, encodeId=d8cd1623335d1, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Blood：单抗原不匹配非亲缘干细胞移植后，环磷酰胺预防GVHD的效果优于标准方法, objectType=article, longId=174850, objectId=6e511e485028, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e511e485028, replyNumber=0, likeNumber=114, createdTime=2019-07-06, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e511e485028, moduleTitle=Blood：单抗原不匹配非亲缘干细胞移植后，环磷酰胺预防GVHD的效果优于标准方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e511e485028)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623334, encodeId=c2a71623334d0, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Vaccibody肿瘤新抗原疫苗在低突变癌症患者中诱导了强烈的T细胞应答, objectType=article, longId=174386, objectId=c95d1e438698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95d1e438698, replyNumber=0, likeNumber=64, createdTime=2019-06-29, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95d1e438698, moduleTitle=Vaccibody肿瘤新抗原疫苗在低突变癌症患者中诱导了强烈的T细胞应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c95d1e438698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623333, encodeId=c8de162333395, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Clin Trans Gastroenterology：前列腺特异性膜抗原在肿瘤相关血管系统中的表达可以预测肝细胞癌预后不良, objectType=article, longId=172263, objectId=26fe1e226384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26fe1e226384, replyNumber=0, likeNumber=18, createdTime=2019-06-28, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26fe1e226384, moduleTitle=Clin Trans Gastroenterology：前列腺特异性膜抗原在肿瘤相关血管系统中的表达可以预测肝细胞癌预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26fe1e226384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623332, encodeId=efd8162333213, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=欧肝指南重磅：HEV抗原可用于检测急慢性戊肝, objectType=article, longId=168839, objectId=0cc31688393c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cc31688393c, replyNumber=0, likeNumber=50, createdTime=2019-06-22, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cc31688393c, moduleTitle=欧肝指南重磅：HEV抗原可用于检测急慢性戊肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cc31688393c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623331, encodeId=b98a162333125, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Circulation：MHC II抗原提呈对于动脉粥样硬化的保护作用, objectType=article, longId=167757, objectId=1ad716e757f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ad716e757f1, replyNumber=0, likeNumber=78, createdTime=2019-06-07, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ad716e757f1, moduleTitle=Circulation：MHC II抗原提呈对于动脉粥样硬化的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ad716e757f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623330, encodeId=9ae816233305a, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=JCLA：不同基因型丙型肝炎病毒RNA与核心抗原的相关性？, objectType=article, longId=166246, objectId=c80a16624632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c80a16624632, replyNumber=0, likeNumber=77, createdTime=2019-05-18, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c80a16624632, moduleTitle=JCLA：不同基因型丙型肝炎病毒RNA与核心抗原的相关性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c80a16624632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623329, encodeId=77321623329e9, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Blood：嵌合抗原受体T细胞疗法的临床效果、管理和神经毒性, objectType=article, longId=163410, objectId=3d86163410a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d86163410a2, replyNumber=0, likeNumber=70, createdTime=2019-04-03, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d86163410a2, moduleTitle=Blood：嵌合抗原受体T细胞疗法的临床效果、管理和神经毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d86163410a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623328, encodeId=3d5a16233280a, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Nature:绝了绝了！癌细胞利用T细胞的胞啃作用，把自己的抗原给了CAR-T细胞，让CAR-T自相残杀, objectType=article, longId=163371, objectId=572d1633e118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=572d1633e118, replyNumber=0, likeNumber=67, createdTime=2019-04-02, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=572d1633e118, moduleTitle=Nature:绝了绝了！癌细胞利用T细胞的胞啃作用，把自己的抗原给了CAR-T细胞，让CAR-T自相残杀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=572d1633e118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623327, encodeId=4caf162332e7e, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Nature：厉害了！中国科学家首次发现，树突细胞会降解肿瘤抗原，阻断这一过程，可将检查点抑制剂的肿瘤控制率提升150%, objectType=article, longId=162995, objectId=e34f16299578, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e34f16299578, replyNumber=0, likeNumber=46, createdTime=2019-03-27, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e34f16299578, moduleTitle=Nature：厉害了！中国科学家首次发现，树突细胞会降解肿瘤抗原，阻断这一过程，可将检查点抑制剂的肿瘤控制率提升150%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e34f16299578)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623326, encodeId=fb861623326fc, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=PNAS：发现DNA解旋酶PfRecQ1调控恶性疟原虫抗原变异基因家族相互排斥性表达的分子机制, objectType=article, longId=160101, objectId=9e3b1601019c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e3b1601019c, replyNumber=0, likeNumber=82, createdTime=2019-02-17, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e3b1601019c, moduleTitle=PNAS：发现DNA解旋酶PfRecQ1调控恶性疟原虫抗原变异基因家族相互排斥性表达的分子机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e3b1601019c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623325, encodeId=23fe16233258b, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=ARCH PATHOL LAB MED：利用游离前列腺特异性抗原， V Leiden因子和甲型肝炎血清学检测的Q-Probes研究, objectType=article, longId=159568, objectId=173d15956832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173d15956832, replyNumber=0, likeNumber=29, createdTime=2019-02-08, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173d15956832, moduleTitle=ARCH PATHOL LAB MED：利用游离前列腺特异性抗原， V Leiden因子和甲型肝炎血清学检测的Q-Probes研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=173d15956832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623324, encodeId=560716233248b, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=肿瘤个性化治疗——肿瘤新抗原Neoantigen疗法首次获批进入临床试验, objectType=article, longId=158976, objectId=44f21589e6dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44f21589e6dd, replyNumber=0, likeNumber=56, createdTime=2019-01-28, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44f21589e6dd, moduleTitle=肿瘤个性化治疗——肿瘤新抗原Neoantigen疗法首次获批进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44f21589e6dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623323, encodeId=bfe016233231d, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=CLIN CHEM：前列腺癌风险相关的单核苷酸多态性影响前列腺特异性抗原糖基化及其功能, objectType=article, longId=157433, objectId=249115e43356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=249115e43356, replyNumber=0, likeNumber=54, createdTime=2019-01-08, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=249115e43356, moduleTitle=CLIN CHEM：前列腺癌风险相关的单核苷酸多态性影响前列腺特异性抗原糖基化及其功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=249115e43356)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗原

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Hypertension：抗原提呈细胞介导高盐诱导的肾脏炎症和高血压的发生

2019-08-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Nat Biotech | 针对肿瘤抗原异质性问题，提出CAR-T与BiTEs联合的免疫疗法，产生强有力的特异性抗肿瘤效应

2019-07-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

中国乙肝表面抗原携带者人数仍为全球多

2019-07-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

JAHA：基于人类白细胞抗原的心脏移植受者风险分层

2019-07-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

人类白细胞抗原Ⅰ（HLA-I）影响肿瘤免疫治疗疗效之探索

2019-07-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

完全个体化肿瘤免疫疗法：一种针对个体化抗原的自体基因编辑的TCR T细胞疗法（NeoTCR-P1）

2019-07-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

JCLA：超敏前列腺特异性抗原水平作为机器人辅助根治性前列腺切除术后生化进展的预测指标？

2019-07-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Blood：单抗原不匹配非亲缘干细胞移植后，环磷酰胺预防GVHD的效果优于标准方法

2019-07-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Vaccibody肿瘤新抗原疫苗在低突变癌症患者中诱导了强烈的T细胞应答

2019-06-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Clin Trans Gastroenterology：前列腺特异性膜抗原在肿瘤相关血管系统中的表达可以预测肝细胞癌预后不良

2019-06-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

欧肝指南重磅：HEV抗原可用于检测急慢性戊肝

2019-06-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Circulation：MHC II抗原提呈对于动脉粥样硬化的保护作用

2019-06-07

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

JCLA：不同基因型丙型肝炎病毒RNA与核心抗原的相关性？

2019-05-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Blood：嵌合抗原受体T细胞疗法的临床效果、管理和神经毒性

2019-04-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Nature:绝了绝了！癌细胞利用T细胞的胞啃作用，把自己的抗原给了CAR-T细胞，让CAR-T自相残杀

2019-04-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Nature：厉害了！中国科学家首次发现，树突细胞会降解肿瘤抗原，阻断这一过程，可将检查点抑制剂的肿瘤控制率提升150%

2019-03-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

PNAS：发现DNA解旋酶PfRecQ1调控恶性疟原虫抗原变异基因家族相互排斥性表达的分子机制

2019-02-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

ARCH PATHOL LAB MED：利用游离前列腺特异性抗原， V Leiden因子和甲型肝炎血清学检测的Q-Probes研究

2019-02-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

肿瘤个性化治疗——肿瘤新抗原Neoantigen疗法首次获批进入临床试验

2019-01-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

CLIN CHEM：前列腺癌风险相关的单核苷酸多态性影响前列腺特异性抗原糖基化及其功能

2019-01-08

科室
- - 订阅+
  - 更多科室
工具
服务